NovaBay Pharmaceuticals, Inc. (NBY)
1.47
+0.26
(+21.49%)
USD |
NYAM |
Mar 16, 16:00
1.42
-0.05
(-3.40%)
After-Hours: 20:00
NovaBay Pharmaceuticals Shareholders Equity (Quarterly) : 1.634M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 74.40M |
| cbdMD, Inc. | 9.008M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 203.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.487M |
| Total Liabilities (Quarterly) | 1.853M |
| Debt to Equity Ratio | 0.5936 |
| Current Ratio | 1.976 |
| Net Debt Paydown Yield | 2.70% |